Open for bids Tender Germany ICB TOT Ref. 152265448

Open House Drug Discount Agreements Belimumab, Atc Tender - 152265448

Tender notice from Germany, published on 10 Nov 2026.

Executive Summary

Title/Summary: Tender for non-exclusive discount agreements for the drug Belimumab (ATC L04AG04) issued by AOK Bayern in Munich, Germany. The earliest contract start date is January 1, 2027, with all contracts ending on December 31, 2028. Interested pharmaceutical companies can submit proposals until November 3, 2028.

Scope Of Work: The tender involves the establishment of non-exclusive discount agreements for Belimumab under an open-house model, allowing interested pharmaceutical companies to enter into identical agreements. Contracts can be initiated at any time during the specified period, with a possibility to terminate with one month's notice. The agreements will be automatically void if a nationwide or state-specific discount contract for the same drug is established. Interested parties must submit a signed declaration of reliability along with the necessary documentation.

Qualification Criterion: Eligible bidders must be pharmaceutical companies that provide a completed and signed declaration of reliability, along with a signed contract and the necessary annex detailing the drug involved. Documents can be submitted either in handwritten form or electronically with a qualified electronic signature. Handwritten submissions must be sent in duplicate to the specified address in Munich, while electronic submissions should be made through the designated procurement portal.

Key facts

Summary
Open House Drug Discount Agreements Belimumab, Atc L04ag04
TOT Ref. No.
152265448
Document Ref. No.
Login to see
Country
Germany
Notice type
Tender
Competition
ICB
Publication date
10 Nov 2026
Bid deadline
03 Nov 2028
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
Public
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Tender details are for registered users

Login to see details

Documents

Tender Notice
Login to view

Similar tenders

Germany Public Procurement Intelligence

Frequently asked questions

The last date to submit a bid for Open House Drug Discount Agreements Belimumab, Atc L04ag04 is 03 Nov 2028. Submit before this date to be considered.

This tender has been issued by AOK BAYERN - THE HEALTH INSURANCE COMPANY in Germany.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 152265448. The purchaser document reference is available after login.

See the Similar Tenders section on this page or browse other tenders from Germany.

This tender falls under Materials and Products, Technology and Equipment in Germany. Suppliers in these sectors can track similar Germany tenders using CPV-based alerts.